Jeil Pharma Holdings: Corporate value-up plan
This is a voluntary filing in which Jeil Pharma Holdings lays out a corporate value-up plan, part of Korea's push for companies with low price-to-book ratios (PBR) to explain how they intend to improve their valuation. It usually outlines management's goals and measures, such as capital efficiency or shareholder returns, but the filing details weren't provided here, so specific targets can't be described. Jeil Pharma Holdings filed this on Oct 22, 2026.
Predicted impact: Low
Routine mandatory-style value-up plan filing with no specific figures or measures disclosed.
Company filing